Behind Closed Doors: FDA Drug Safety Board Will Keep Its Decisions Private
Executive Summary
The pharmaceutical industry and other FDA stakeholders should not hold their breath waiting for more details about the agency's Drug Safety Oversight Board recommendations or the extent of internal debate and disagreement at its monthly non-public meetings